FDA Recalls Compounded Papaverine-Phentolamine-PGE1 Injectable Due to Insanitary Conditions
The FDA is recalling compounded Papaverine-Phentolamine-PGE1 injectable products from Professional Compounding Pharmacy in Oregon due to insanitary conditions observed during compounding.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text explicitly identifies the agency classification as Class II. According to the severity rubric, an FDA Class II recall is assigned a score of 4 (Severe), particularly when involving sterile drug compounding issues that imply significant risk.
Plain-English summary
The U.S. Food and Drug Administration (FDA) is recalling specific lots of compounded Papaverine-Phentolamine-PGE1 injectable products manufactured by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy in Corvallis, Oregon. The recall involves 13 prescription vials in 5ml, 6ml, 9ml, and 10ml sizes. These products were dispensed in Oregon between September 1, 2018, and February 20, 2019.
The recall was initiated because of a lack of processing controls, specifically insanitary conditions observed during the compounding of sterile drugs during a recent FDA inspection. The agency has classified this as a Class II recall.
Patients who have received these specific compounded injectable products should contact their healthcare provider or the pharmacy for further instructions on how to proceed. The recall is limited to the specific lot numbers and distribution dates listed in the official FDA notice.
The recalled product
- Product
- PAPAVERINE-PHENTOLAMINE-PGE1 30-1 MG-10 MCG/ML* INJECTABLE, (a) 5ml, (b) 6ml, (c) 9ml (d) 10ml, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330
- Category
- Drug — Compounded Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lot: (a) 03102018@27
- 07112018@18
- 08112018@11
- 16112018@15
- 28112018@7
- 14122018@37
- 16112018@41
- 03012019@9
- (b) 2012019@32
- 23012019@59
- (c)07022019@19
- 07022019@1
- (d)19122018@25
- distributed between 09-01-2018 to 02-20-2019.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 25 recalled by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 25 products in this recall →Related recalls
Same manufacturer · Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy
See all →- SevereFDA Recalls Compounded Sodium Chloride Eye Drops Due to Insanitary Conditions
FDA (Drugs) · 2019-04-17
- SevereFDA Recalls Compounded Papaverine-Phentolamine-PGE1 Injectable Due to Insanitary Conditions
FDA (Drugs) · 2019-04-17
- SevereFDA Recalls Compounded Injectable Drug Due to Insanitary Compounding Conditions
FDA (Drugs) · 2019-04-17
- Severe
- Severe
Same hazard · contamination
See all →- HighMedline Recalls Surgical Convenience Kits Due to Contaminated Components
FDA (Devices) · 2026-09-02
- HighMedline Recalls 263 Surgical Convenience Kits Due to Contamination
FDA (Devices) · 2026-09-02
- HighMedline Recalls 71 Convenience Kits Due to Contaminated Component
FDA (Devices) · 2026-09-02
- HighMedline C-Section Convenience Kits Recalled for Contaminated Components
FDA (Devices) · 2026-09-02
- HighMedline Recalls 419 Surgical Kits Due to Contaminated Component
FDA (Devices) · 2026-09-02